Nexstim (NXTMH.HE) Stock Analysis & AI Equity Report

Medical - Devices EUR Explore free reports

Nexstim (NXTMH.HE) overview

Nexstim (NXTMH.HE) stock analysis and AI equity research. For the latest completed financial year, 2025, Nexstim reported revenue of EUR 11.0m and operating profit of EUR 0.6m; the year-end share price was 14.20 EUR and market capitalisation was EUR 102m. Nexstim is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Nexstim's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueEUR 4.2mFY 2025
Share price14.20 EURFY 2025 year end
RevenueEUR 11.0mFY 2025
Operating profitEUR 0.6mFY 2025
Net earningsEUR 0.6mFY 2025
Market capitalisationEUR 102mFY 2025 year end

Figures updated on 2026-07-27. Data will be refreshed during report generation.

About Nexstim

Nexstim Plc is a Finnish medical technology company that develops and sells navigated transcranial magnetic stimulation systems for brain diagnostics, neurosurgical planning and therapy. Its NBS 6 platform and related software are used for mapping motor and language areas and for treating conditions such as major depression and chronic neuropathic pain, with sales supported by direct and partner channels.

Generate the Nexstim report

Nexstim is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, typically within about 30 minutes

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Nexstim and represent the latest completed financial year (2025). See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Nexstim

Each is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by what other analysts said the work added over the engine's report — a score out of five from people who had to read it to give it.